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tive antioxidant [6] [7] [8] [9] . There are many reports on mushrooms containing more than one polysaccharide with antitumor activity 10) . An interesting example is Agaricus blazei Murill. A. blazei is an edible mushroom, native to Brazil and presently cultivated in other areas, including Japan, Korea, China, Indonesia. It has recently received attention in folk medicine due to its use in the treatment of different ailments. A. blazei is considered as a health food in many countries after it was reported to be a source of antitumor and immunoactive compounds [11] [12] [13] [14] . The water extract of A. blazei has potent antitumor activity in tumor-bearing mice 15, 16) . Protein-bound polysaccharides isolated from fruiting bodies of the A. blazei have also shown anti-tumor activity in tumor-bearing mice through activation of specific and non-specific immune response [17] [18] [19] . A. blazei extract, mainly glucan has selective tumoricidal activity mediated via natural killer (NK) cell activation and promote health 10, 15, 20) . Most of studies had taken the approach of isolating pharmaceutically active mushroom compounds. The polysaccharides from A. blazei have cytotoxic action on tumor cells through immunomodulatory activities. From the water extract(s) of A. blazei, a protein-(1,6) b-D-glucan complex which contained 50.2% carbohydrate and 43.3% protein, was isolated 21) . This protein-polysaccharide complex was characterized by growth inhibition of sarcoma-180 implanted in mice and by developing immunomodulatory properties 22, 23) , possibly due to immunological mechanisms involving the action of various immunocompetent cells 13, 24) . Furthermore, a highly branched (1, 3)-b-glucan segment forms the active center of the antitumor activity 25) . Thus, b-(1, 6)-glucan with b-(1, 3)-branched chains have exhibited strong anticancer activity by increasing immune-competent cell activity 26) . There are a few reports on liposomized glucan-treatment. For example, co-administration of liposomized glucan and praziquantel efficacy (%) was significantly higher than after treatment with either compound alone, particularly in the Mesocestoides vogae infected peritoneal cavity to the liver 27) . It is anticipated that encapsulating anticancer glucans with n-3 polyunsaturated fatty acid (PUFA) inserted marine phospholipids in the form of liposomes might promote the anticancer effect of glucans. Therefore, in this study, we investigated the effects of glucans from A. blazei encapsulated with n-3 polyunsaturated marine phospholipid liposomes and unencapsulated glucans on myeloma sp2 cell induced cancer in mice.
EXPERIMENTAL
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Caco-2 cells were grown in MEM with 26.2 mM sodium bicarbonate, 100 IU/mL penicillin, 100 mg/mL streptomycin, 1% non-essential amino acids, and 10% heat-incubated FBS in a 95% air-5% CO 2 atmosphere at 37 . Raji cells were grown in RPMI 1640 medium supplemented with 10% heat-incubated FBS in the same incubator. The cells were grown in 25-cm 2 flasks, and subcultured at fourday intervals at a concentration of 5 10 4 cells/mL.
3
Phosphatidylcholine (PC) was separated from squid meal phospholipid following our previous method 28) . Just in brief, the phospholipid from squid meal was applied to a silica gel chromatography column and eluted with chloroformmethanol to afford PC. PC was monitored on thin layer chromatography (TLC) by spraying with Dragendorff reagent and by comparing with an authentic PC standard.
4
Phosphatidylserine (PS) was obtained from squid meal PC via PLD-mediated transphosphatidylation as described by Hosokawa et al. 29) . Briefly, PC was dissolved in 2.5 mL of ethyl acetate and then 3.0 mL of 0.2 M acetate buffer (pH 5.5) containing certain amounts of PLD, CaCl 2 , albumin and L-serine was added. The mixture was incubated at 30 for 24 h with 500 rpm stirring. After the reaction, the solution was mixed with chloroform/methanol/water (6/3/1.3), and the chloroform layer was collected. It was evaporated and loaded on TLC plates to obtain the PS.
5
Individual methyl esters were derived from the PC or PS
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samples following the method of Lepage and Roy 30) with slight modification. The dried samples were dissolved in 5% methanolic-HCl. The mixture was shaken, kept at 80 for 2 h and then 2 mL water and 3 mL hexane were added. The hexane layer was collected, concentrated and subjected to gas chromatographic analysis with a 0.5 mm PEG-20M liquid phase-coated 40 m 1.2 mm diameter G-300 column (Chemicals Evaluation and Research Institute, Saitama, Japan) connected to a Hitachi 163 gas chromatograph (Hitachi Co. Ltd., Ibaraki, Japan) that was equipped with flame ionization detector. The temperatures of the column, detector and injection port were 170, 240 and 250 , respectively. The fatty acids were identified by comparing the peak relative retention times with authentic standards (St. Louis, MO, USA) following the method of Takahashi et al. 31) .
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A blazei The powder from dehydrated and milled mushrooms (25 g ) was suspended in 200 mL distilled water. Then left for 5 h at room temperature with 200 rpm stirring. The suspensions were centrifuged at 5000 rpm for 30 min and light orange color extracts were obtained. The supernatant was freeze dried. And this A. blazei Murill water extract was stored at -50 until use.
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To confirm whether the intestinal epithelial monolayer is formed or not, transport of lucifer yellow was measured. This experiment was performed following our previous paper 32) . Briefly, Caco-2 cells were plated at a density of 2 10 5 cells/cm 2 onto a 12 mm polycarbonate transwell filter with 0.4-mm pores and a surface area of 0.6 cm 2 (Millipore Corporation Ltd., Bedford, MA, USA). Before each experiment, cells were washed three times with PBS and pre-equilibrated for 30 min in Hanks balanced salt solution (HBSS) containing 10 mM MES at pH 6.0 in the apical (AP) chamber and HBSS containing 10 mM HEPES at pH 7.4 in the basolateral (BL) chamber. 0.5 mM Lucifer yellow (LY) HBSS solution (pH 6.0) was applied on the Caco-2 cell monolayer in the AP chamber. After incubation at 37 for 2 h, the HBSS in the BL chamber was collected, and the concentration of LY was determined by measuring the fluorescent intensity with a Hitachi F-2000 fluorescence spectrophotometer (Hitachi Co. Ltd., Ibaraki, Japan). The excitation and emission wavelengths used were 430 and 540 nm, respectively.
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Liposomes were prepared by a lipid film hydration method 33) from a lipid mixture film containing PC, PS and cholesterol in a molar ratio of 1:1:2. The lipid film was then hydrated with water or with Agaricus blazei Murrill water extract to exfoliate phospholipid bilayers by vigorous vortex mixing for 5 min. The liposomes thus formed were extruded 5 times through two stacked polycarbonate membrane filter (Whatman Inc. Newton, MA, USA) with a pore size of 400 nm. The particle size distribution in the sample was analyzed by dynamic light scattering using a particle size analyzer LB-500 (HORIBA, Japan).
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Liposomes were prepared in 150 mM calcein solution (10 mM Tris-HCl, 145 mM NaCl, pH 7.4). Then it was ultra centrifuged twice to remove the unencapsulated calcein. The liposome solution thus prepared was dispersed into 10 mM Tris-HCl buffer to make the liposome concentration 10 mmol/mL. Stability evaluation of the liposomes in the digestive juice model was done as follows; One hundred mL of the liposome solution was added to 1.9 mL of each digestive juice model and incubated for an hour at 37 . Digestive juice models employed were 10 mM Tris-HCl (145 mM NaCl, pH 7.4), same buffer with pH 2.0, 10% bovine bile in PBS, pH 7.2, 2.8% pancreatin solution in PBS pH 7.2. To the 0.5 mL of Tris-HCl buffer (145 mM NaCl, pH 2.0) solution, same volume of Tris-HCl buffer (145 mM NaCl, pH 9.5) was added, then ultra centrifuged at 95000 g, 10 min (4 ) in order to remove the leaked calcein in the digestive juice model. As for the bovine bile solution and pancreatin model, ultrafilteration (Millipore, Ultrafree-CL, 0.1 mm) at 3,300 g for 30 min (4 ) was carried out to recover the leaked calcein. The excitation and emission wavelengths used for the calcein amount determination were 490 and 520 nm, respectively.
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Calcein was entrapped into liposomes by preparing liposome in 0.1 mM calcein solution (10mM Tris-HCl, 145 mM NaCl, pH 7.4). Then 40 mL of this liposome suspension was added to 2.0 mL of 10 mM Tris-HCl buffer. Fluorescent intensity at excitation and emission wavelengths of 490 and 520 nm, respectively, using a Hitachi F-2000 fluorescence spectrophotometer was measured (Ft). By adding 10 mM cobalt chloride solution for 20 mL uncapsulated calcein was quenched to give the fluorescent intensity only from the encapsulated calcein (Fin). Finally, by adding 20% Triton -100 for 20 mL, all the calcein was quenched by exposing the encapsulated calcein to Co 2+ (Fq). Trapping efficiency was calculated as follows.
Trapping efficiency (%) = (Fin Fq r)/(Ft Fq r) 100 Where r is a volume correction factor
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The transepithelial electrical resistance (TER) was measured using a Millicell (R) ERS (Millipore Co., Bedford, MA, USA), to ensure the integrity of the monolayers formed on the filter. TER measurements were started during the preequilibration time in HBSS and continued during the treatment. Values were recorded every 30 min over the experimental period. Control filters were maintained with only HBSS for 3 h experiments. TER data was expressed as relative TER values against initial.
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Caco-2 cells were grown on polycarbonate transwell filter as described before 32) . Raji cells in RPMI: DMEM 1:2 (8. 3 10 4 cells/mL) were added to the basolateral chamber then cocultured for 4-6 days. If some of the Caco-2 cells have differentiated into M-cells by a soluble induction factor secreted from Raji cells, the alkaline phosphatase activity should decline. Alkaline phosphatase activity was visualized by use of ELF 97 endogenous phosphatase detection kit (Molecular Probes Inc., Eugene, USA) on a slide glass with cell monolayer on it. Namely, the cell monolayer was fixed with PBS containing 10% formalin (pH 7.4) and then washed three times with PBS. The cells were dipped into PBS containing 0.2% Tween 20 (pH 7.4) for 10 min and then rinsed with PBS for more than 10 min. The cell monolayer filter were carefully taken out and transferred to a slide glass. Reaction itself was terminated with PBS (pH 8.0) containing 25 mM EDTA and 5 mM L-phenylalanine.
Another index employed to confirm the differentiation into M-cells was checking latex beads import. The Caco-2 cell monolayers were incubated for 30 min with 2% FCS containing HBSS. HBSS (2% FCS) was added to fluorescent latex bead. Then after 30 min, it was centrifuged at 3000 g and the supernatant was removed. Lump was separated into individual particles while rinsing with a sonicator. This rinsing was repeated for several times. Finally, the fluorescent intensity of the recovered HBSS from the basolateral chamber was measured. The excitation and emission wavelengths used were 365 and 415 nm, respectively. Number of the latex beads was counted from a calibration curve showing the relationship between the fluorescent intensity and the number of the beads.
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b Caco-2 and Raji cells were washed three times with HBSS containing 2% FCS. It was incubated at 4 or 37 for 30 min with 400 mL and 600 mL HBSS containing 2% FCS in apical and basolateral chamber, respectively. Then, it was taken in new plate inserts and incubated at 4 or 37 for 30 min with 400 mL and 600 mL HBSS containing 2% FCS in apical and basolateral chamber, respectively. Transportation of b-glucan encapsulated liposomes from apical to basolateral chamber was determined by limulus test using Endospect ® ES-50M Set (Seikaguku Corporation, Tokyo, Japan).
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Six-week-old male BALB/c nu/nu mice were purchased from Hokudo Ltd. (Abuta, Hokkaido, Japan). Sp-2 myeloma (1.5 10 5 cells/mouse) was inoculated subcutaneously. Mice were acclimatized for 1 week. All animals were provided free access to drinking. Weanling BALB/c mice were divided into five groups. After 20 days of myeloma sp2 cell inoculation into mice, liposomal drinks were orally administered for 3 weeks. Mice were provided with drinks containing 1.0 mg/mL squid phospholipid liposome alone, 0.5 mg/mL A. blazei water extract alone, 1.0 mg/mL squid phospholipid liposome with 0.5 mg/mL A. blazei water extract mixture, and 1.0 mg/mL squid phospholipid liposome with 0.5 mg/mL A. blazei water extract partially encapsulated in groups II, III, IV and V, respectively. A control (group I) was also maintained. The orally administered liposomal drink amount per mouse was approximately 5 mL per day for all groups.
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After 20 days of myeloma sp2 cell implantation, tumors were formed. The tumor size was determined through direct measurement with calipers. After 3 weeks of drinks serving, the mice were sacrificed, and the tumors were carefully removed and weighed.
16
Statistical analysis for comparison between two groups was performed using student's t-test. Data was expressed as means ±standard deviations (SD). A difference was considered significant at P. The resulting P values for each group are indicated in the figures.
RESULTS
1
Fatty acid profiles of squid meal PC and PS are shown in . The major fatty acids were 16:0, and 22:6 in squid meal PC, then 20:5. There was no change in fatty acid profile during transphosphatidylation.
2
The mean particle sizes of freeze-thawed liposomes of PC/PS/Chol=1:1:2 ranged from 46.2 to 560, 65.8 to 504 and 129 to 1102 nm, respectively for 0, 4 and 5 times freezethawing, respectively ( ).
3
As shown in , incubation at pH 2.0 Tris-HCl solution containing 145 mM NaCl caused the release of 4.2 ± 0.2% and 11.7 ± 4.4% of entrapped calcein from liposomes composed of PC and PC/PS/Chol (1: 1: 2 molar ratio), respectively. Treatment with 10% bovine bile acid resulted
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in 90.8±19.1, 33.9±7.9, 58.8±6.2 and 13.1±1.1% leakage of calcein from liposomes composed of PC, PC/Chol (7: 2 molar ratio), PC/PS/Chol (7: 3: 2 molar ratio), and PC/PS/Chol (1: 1: 2 molar ratio), respectively. The leakage of calcein from the liposomes composed of PC, PC/Chol (7: 2 molar ratio), PC/PS/Chol (7: 3: 2 molar ratio), and PC/PS/Chol (1: 1: 2 molar ratio) when treated with 2.8% pancreatin were 45.7 ± 3.4, 52.9 ± 2.2, 45.2 ± 1.6, and 29.6 ± 1.8%, respectively. These results suggest that the stability of liposomes containing PC/PS/Chol (1:1:2 molar ratio) is relatively high.
4
PC/PS/Chol = 7: 3: 2 and 1: 1: 2 had entrapped calcein more than PC alone and PC/Chol ( ). However, the trapping efficiency remained 8% at the most. 
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The LY flux across the Caco-2 cell monolayers is shown in after incubation with PC/PS/Chol (1: 1: 2 molar ratio) and PC/PS (1:1 molar ratio) liposomes. The perme- 
7 b 2
The transportation of b-glucan and b-glucan-containing liposomes through the Caco-2 or cocultured (M-cell) monolayers was determined by limulus test. Transportation of bglucans from apical to basolateral layers was 30 and 72 pg/mL for Caco-2 and M-cell respectively. It was 62 and 56 pg/mL when treated with b-glucans encapsulated liposomes and b-glucans and liposomes mixture on coculture monolayers. We observed a diluted milk looking solution (which is no doubt liposomes) coming out to the outer well (data not shown). But transportation increase of b-glucan across the Caco-2 monolayers was not clear for the liposome form donation. It may due to methodological error. We should increase the amount of encapsulated b-glucan to minimize the methodological error.
8
The drinks were well accepted by the mice. The consumed volume of the drinks by myeloma sp2 bearing BALB/c mice is presented in . The weight gain was measured once a week. Mean weight of body in all groups is shown in . There was no significant difference in drinks intake, or body weight gain between mice among the different groups. 
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Murill water extract and squid phospholipid were administrated simultaneously in a simple mixture form, promotional effect on cancer tumor suppression was observed. And when A. blazei Murill water extract was partially encapsulated with squid phospholipid liposome with total administrations being 105 mg/mouse for both components, promotional effect on cancer tumor suppression was more prominent. Moreover, disappearance of tumors occurred in the group administered with the partially encapsulated form.
If we succeed in encapsulating larger amounts of A. blazei Murill water extract in the liposomes, there should be a significant difference in tumor sizes between groups IV and V.
DISCUSSION
Mushroom constituents may inhibit promotion or progression by exerting direct cytotoxicity against tumor cells 15) , interfering with tumor angiogenesis 14) , or upregulating other nonimmune tumor-suppressive mechanisms. The whole-mushroom extracts contain compounds that may modulate tumorigenesis and carcinogenesis at different stages and/or may act at the same stage but through different mechanisms. Thus, it could potentially provide additive, or even synergistic, effects in the prevention and treatment of cancer 34) . In the current study, we found inhibition of myeloma in vivo with A. blazei extract only and inhibition was more efficient with A. blazei extract encapsulated with marine phospholipid liposomes.
Various polysaccharides and protein-bound polysaccha-
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J. Oleo Sci. 56, (4) 179-188 (2007) rides have been isolated from the fruiting bodies of the A. blazei and have shown anti-tumor activity in tumor-bearing mice. These compounds appear to stimulate the host immune response by enhancement of macrophage, NK cells and cytolytic T lymphocytes activities, which participate in the antitumor response in the sarcoma 180 or Meth A fibrosarcoma-bearing mice systems 19) . Substances occurring in the powdered A. blazei meal may stimulate the hepatic detoxifying enzymatic system or the antioxidant free radical scavenging activities 35) . A. blazei fed in dry powdered form to Wister rats at 10% of the diet exhibited significant chemopreventive influence on the promoting phase of the rat chemical hepatocarcinogenesis 36) . Similar antimutagenic effects were reported for diets containing powder of other mushroom Lentinula edodes 37, 38) . It was observed that the NK cell activity was maintained at a more significant level in the gynecological cancer patient groups undergoing chemotherapy when A. blazei was orally consumed. This suggests that A. blazei extracts might have some beneficial effects on innate immunity in gynecological cancer patients undergoing chemotherapy. NK cells display dramatic effects on the reduction of tumor growth as well as on the inhibition of metastatic tumors 39) . The mechanisms of controlling NK cell cytotoxicity are gradually being elucidated but still remain fragmentary. It has also been reported that direct intratumoral injection of A. blazei extract can induce apoptosis and cell-cycle arrests of tumor cells 15) . Additionally, it was found that A. blazei extract consumption reduced some chemotherapy-related side effects in cancer patients. In general insomnia, appetite, alopecia, body weight, nausia/vomiting, emotional conditions, discomfort and general body strength were all improved, indicating the A. blazei consumption could be effective to reduce some chemotherapy-associated side effects 40) . A. blazei extracted glucan encapsulated n-3 PUFA inserted marine phospholipid might be more useful to assist A. blazei extracted cancer therapy because they should decrease side effects and promote the effectiveness of cancer cell differentiation. An in vitro study shown marine PC and PS induced sodium butyrate-mediated growth inhibition, differentiation and apoptosis in colon carcinoma Caco-2 cells 28) . The results of the current in vivo study provide the first evidence that oral administration of A. blazei extract directly or encapsulated liposomal form suppressed myeloma in mice. It has been reported that application of extracts from the medicinal mushrooms Phellinus igniarius and Agrocybe cylindracea could inhibit chemical carcinogen-induced skin cancers in mouse models by up to 88% 41) . In addition, b-glucan of A. blazei inhibited growth of Meth A tumor in BALB/c mice 42) . Mushrooms of the higher Basidiomycetes origin showed activity against many experimental tumors, including sarcoma 180, mammary adenocarcinoma 755, leukemia L-1210, and HeLa cell lines 43) . Water extract of Phellinus rimosus inhibited growth of Dalton's lymphoma ascites in Swiss albino mice 44) . And extract of Lepista inversa inhibited growth of leukemia and Lewis lung carcinoma in DBA/2 mice 45) . Moreover, oral administration of b-glucan reduced peritoneally disseminated metastasis in a mouse model using human ovarian cancer HRA cells and 3LL lung cancer in mice 46) . Furthermore, epidemiological studies from selected area in Japan and Brazil suggest that prolonged consumption of the medicinal mushrooms Flammulina velutipes and A. blazei were associated with lower overall rates of cancer mortality 47) . The oral administration of A. blazei extract and/or marine phospholipid had no effect on body weight gain in myeloma-bearing mice. Our findings suggest that the antitumor effect of b-glucan and/or marine phospholipid was demonstrated with the absence of side effects such as weight loss, which might indirectly affect cancer. The results obtained in this study suggest that though the suppression mechanism is still unclear, combined administration of A. blazei extract and marine phospholipid might be useful in myeloma sp2 therapy.
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